Biohaven Ltd. (BHVN)
NYSE
Closed
Oct 7, 2026
Day's Range
11.8552 wk Range
7.48Overview - BHVN - Biohaven Ltd.
Key Statistics
Valuation
Enterprise Value
1.97B
P/E (Trailing)
‪-1.87‬
P/E (Forward)
‪-6.87‬
PEG Ratio
‪0.03‬
Price / Book
‪158.88‬
EV / EBITDA
‪-3.79‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-71.97%‬
Return on Equity
‪-799.46%‬
Ownership
Shares Outstanding
151.01M
Float
116.57M
Short % of Shares Outstanding
‪17.32%‬
Held by Insiders
‪11.20%‬
Held by Institutions
‪95.73%‬
Price stats
Beta
‪3.17‬
50-Day Avg
‪14.10‬
200-Day Avg
‪12.04‬
Analyst Consensus
17 analysts
Average price target
‪$ 21.73‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BHVN - Biohaven Ltd.
Peers - BHVN - Biohaven Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on NYSE.
- BHVNNYSEBiohaven Ltd.1.94BMarket Cap-23.39%52-week change-1.88P/E (Trailing)‪0.00%‬Profit Margin
- BIONYSEBio-Rad Laboratories Inc.9.87BMarket Cap+16.25%52-week change44.96P/E (Trailing)‪8.58%‬Profit Margin
- BSTNYSEBlackRock Science and Technology Trust1.76BMarket Cap+21.83%52-week change7.02P/E (Trailing)‪0.00%‬Profit Margin
- BCXNYSEBlackRock Resources & Commodities Strategy Trust991.85MMarket Cap+22.29%52-week change4.66P/E (Trailing)‪0.00%‬Profit Margin
- ANRONYSEAlto Neuroscience Inc.973.20MMarket Cap+73.63%52-week change-11.34P/E (Trailing)‪0.00%‬Profit Margin
- ATTONYSEAttovia Therapeutics Inc.783.83MMarket Cap-27.55%52-week change-7.23P/E (Trailing)‪0.00%‬Profit Margin
- ARMPNYSEArmata Pharmaceuticals, Inc.130.88MMarket Cap+9.09%52-week change-0.73P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - BHVN - Biohaven Ltd.
About
Biohaven Ltd. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies in immunology, obesity, neuroscience, and oncology. The company’s current portfolio includes drug candidates for neurological and neuropsychiatric disorders, epilepsy, pain, neuroinflammatory…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
